Health Law Alliance (“HLA”) is proud to announce another major victory in defending an independent community pharmacy against OptumRx (“Optum”)’s network termination. After Optum issued a formal termination notice, citing inventory discrepancies, alleged non-compliance with prior corrective actions, and other findings frequently raised in Pharmacy Benefits Manager (“PBM”) audits, the pharmacy retained HLA to challenge and overturn Optum’s decision. Through strategic advocacy, meticulous appeal submissions, and deep expertise in PBM enforcement and healthcare law, HLA successfully secured a full reversal of the termination.
This result highlights the critical importance of prompt, substantive, and legally grounded responses to PBM audit findings and network actions, and underscores the value of engaging experienced PBM attorneys who understand the complexities of PBM audits, pharmacy operations, and federal and state regulatory frameworks.
Termination Based on Common PBM Audit Allegations
Optum’s termination notice alleged several discrepancies, including inventory shortages and related issues, concerns that pharmacies nationwide increasingly face as PBMs intensify their audit activities. These adverse findings often serve as the basis for aggressive PBM enforcement that can trigger significant recoupments, immediate withholding of reimbursement, and network terminations, which leads to loss of access to critical patient populations, all of which can destabilize pharmacy operations overnight.
HLA’s Immediate and Comprehensive Legal Strategy
Upon being retained, HLA immediately assembled a comprehensive, legally grounded response. Our team addressed each alleged deficiency in detail, provided corrective action measures, and demonstrated operational improvements, presented extensive legal arguments establishing that termination was unwarranted, unsupported, and contrary to applicable federal and state laws. Moreover, HLA’s attorneys worked closely with pharmacy leadership to document a strong commitment to best practices, regulatory compliance, and ongoing audit-readiness.
After reviewing multiple detailed submissions from HLA, Optum reversed its termination decision, allowing the pharmacy to remain in-network and continue serving its patients and community.
Why Pharmacies Choose HLA for PBM Audit and Termination Defense
HLA brings unmatched experience to pharmacy–PBM disputes. Our PBM practice is led by attorneys with years of experience dealing directly with PBM audits, network terminations, as well contractual and regulatory compliance issues.
Our representation goes far beyond drafting an appeal letter. We guide pharmacies through comprehensive corrective strategies, documentation enhancement procedures, regulatory compliance, and operational changes PBMs often require for continued network participation.
When a pharmacy retains HLA, our team conducts a deep legal and factual review of the allegations and prepares a detailed, evidence-based response addressing each issue with precision. Our PBM attorneys collaborate closely with each client to prevent termination, reverse termination, or negotiate alternative corrective pathways that preserve network access, wherever possible.
Our approach is thorough, strategic, and rooted in a sophisticated understanding of PBM expectations, audit methodologies, and contractual enforcement mechanisms.
A Proven Track Record of Protecting Pharmacies
This Optum reinstatement is another example of HLA’s unwavering commitment to defending pharmacies against PBM overreach and protecting their ability to continue serving their patients. While no two PBM matters are identical, the principles remain constant: timeliness matters, documentation matters, and having the right legal team can mean the difference between business survival and closure.
How HLA Can Help
If your pharmacy is facing a PBM audit, recoupment demand, or network termination, you should not navigate the process alone. HLA stands ready to provide strategic guidance, aggressive advocacy, and experienced representation to protect your pharmacy and your patients.
To learn more about how HLA can assist your pharmacy, contact us today for a free legal consultation.
MORE ARTICLES BY CATEGORY
What to Expect in a Wound Care Audit - And Why You Shouldn’t Go It Alone
In 2025, wound care audits have become a top enforcement priority for federal and private payors, leaving providers unprepared and facing thousands in recoupments. Understanding how wound care audits progress is crucial to defending your practice from unjust penalties, and engaging counsel early is essential to protecting your practice. Learn how Health Law Alliance can help prepare a strategy-driven defense designed to minimize risk and preserve your practice’s reputation.
Read More >>DOJ Targets Florida Dermatology Practices’ Wound Care Coding
Earlier this year, the DOJ announced a settlement with Florida dermatology practices over allegations of false wound care claims submitted to Medicare. Learn more about the settlement and how Health Law Alliance can protect your wound care practice before regulators come knocking.
Read More >>When a Wound Care Audit Hits, Call Counsel First: How Specialized Attorneys Protect Your Practice
Medicare is intensifying scrutiny of wound care, OIG’s work plan spotlights skin-substitutes and related services, while CMS’s CERT program still finds sizable fee-for-service improper payments - so a targeted audit can escalate quickly to payment suspensions and referrals if mishandled.
Read More >>When Inventory Discrepancies Become Audit Nightmares: Understanding One of the Most Common and Costly Audit Findings
Inventory reconciliation is one of the most scrutinized areas in PBM and payer audits and even small discrepancies can trigger major financial, reputational, and regulatory fallout.
Read More >>
